SCHEMBL23210634

SCHEMBL23210634

COC(=O)c1ccc(Oc2ccc(C3[C@H]4C[C@@H]5C[C@@H](C[C@H]3C5)C4)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
EPHX2 P34913 3/20 0.45
MAPT P10636 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.44
CASP1 P29466 2/20 0.44
CASP7 P55210 2/20 0.44
ATM Q13315 2/20 0.44
TSHR P16473 2/20 0.44
KMT2A Q03164 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
GLA P06280 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21656813 1.00 CA1 (0.47) CA1CA2EPHX2MAPTALDH1A1
SCHEMBL23210666 0.85 LMNA (0.51) ALDH1A1KDM4ETSHRSMN1; SMN2
SCHEMBL23210665 0.85 LMNA (0.51) ALDH1A1KDM4ETSHRSMN1; SMN2
SCHEMBL23210709 0.85 LMNA (0.48) CA1CA2EPHX2MAPTALDH1A1
SCHEMBL23210710 0.85 LMNA (0.48) CA1CA2EPHX2MAPTALDH1A1
SCHEMBL21628644 0.84 HPGD (0.61) EPHX2HPGDTSHRSMN1; SMN2
SCHEMBL21628646 0.84 HPGD (0.61) EPHX2HPGDTSHRSMN1; SMN2
SCHEMBL21628558 0.84 USP2 (0.43) EPHX2MAPTALDH1A1HPGDKMT2A
SCHEMBL21628560 0.84 USP2 (0.43) EPHX2MAPTALDH1A1HPGDKMT2A
SCHEMBL23210653 0.84 PARP10 (0.49) CA1CA2EPHX2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK CA1 4881/4885CA2 4416/4885EPHX2 3906/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK CA1 4881/4885CA2 4416/4885EPHX2 3906/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR CA1 3602/4885CA2 1477/4885EPHX2 3372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.